<?xml version='1.0' encoding='utf-8'?>
<document id="15526201"><sentence text="Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice."><entity charOffset="81-93" id="DDI-PubMed.15526201.s1.e0" text="geldanamycin" /></sentence><sentence text="There is currently much interest in developing analogues of the benzoquinone ansamycin geldanamycin that may overcome the limitations of 17-(allylamino)-17-demethoxygeldanamycin (17AAG), which is the first known inhibitor of heat shock protein 90 (Hsp90) to enter clinical trials"><entity charOffset="64-99" id="DDI-PubMed.15526201.s2.e0" text="benzoquinone ansamycin geldanamycin" /><entity charOffset="137-177" id="DDI-PubMed.15526201.s2.e1" text="17-(allylamino)-17-demethoxygeldanamycin" /><entity charOffset="179-184" id="DDI-PubMed.15526201.s2.e2" text="17AAG" /><pair ddi="false" e1="DDI-PubMed.15526201.s2.e0" e2="DDI-PubMed.15526201.s2.e0" /><pair ddi="false" e1="DDI-PubMed.15526201.s2.e0" e2="DDI-PubMed.15526201.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15526201.s2.e0" e2="DDI-PubMed.15526201.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15526201.s2.e1" e2="DDI-PubMed.15526201.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15526201.s2.e1" e2="DDI-PubMed.15526201.s2.e2" /></sentence><sentence text=" Studies were performed to assess whether cassette dosing, the coadministration of several compounds to a single animal, is a suitable approach to evaluate the preclinical pharmacokinetics of geldanamycin analogues in high throughput"><entity charOffset="192-204" id="DDI-PubMed.15526201.s3.e0" text="geldanamycin" /></sentence><sentence text="" /><sentence text="Five geldanamycin analogues (17AAG, NSC 255110, NSC 682300, NSC 683661, NSC 683663) were administered intravenously to mice in combination at 5 mg/kg each and as single agents at 5 mg/kg and 50 mg/kg, or 12"><entity charOffset="5-17" id="DDI-PubMed.15526201.s5.e0" text="geldanamycin" /><entity charOffset="29-40" id="DDI-PubMed.15526201.s5.e1" text="17AAG" /><pair ddi="false" e1="DDI-PubMed.15526201.s5.e0" e2="DDI-PubMed.15526201.s5.e0" /><pair ddi="false" e1="DDI-PubMed.15526201.s5.e0" e2="DDI-PubMed.15526201.s5.e1" /></sentence><sentence text="5 mg/kg for NSC 682300" /><sentence text=" The compounds were also incubated with mouse liver microsomes individually and in combination at 15 microM each" /><sentence text=" Quantitative analysis was performed by LC/MS/MS" /><sentence text=" Plasma and tissue pharmacokinetic parameters were evaluated by non-compartmental analysis" /><sentence text=" In vitro metabolic stability was assessed by monitoring disappearance of the parent compound" /><sentence text="" /><sentence text="Of the compounds that were detectable following individual administration at 5 mg/kg, 17AAG and NSC 683661 exhibited nonlinear pharmacokinetics"><entity charOffset="86-90" id="DDI-PubMed.15526201.s12.e0" text="17AAG" /></sentence><sentence text=" In addition, the plasma area under the curve (AUC) and the half-life of these compounds was greater following cassette dosing at 5 mg/kg compared to single administration at the same dose" /><sentence text=" When pharmacokinetic parameters were calculated up to the same time point following cassette and individual administration at the higher dose, three of the compounds displayed non-linear increases in AUC and slower clearances following cassette compared to single compound dosing" /><sentence text=" When all measurable concentrations at the higher dose were included, the half-life of NSC 683663 was nine-fold longer following individual compared to cassette administration" /><sentence text=" 17AAG displayed the highest AUC following cassette dosing, whereas NSC 683663 displayed the highest AUC following single-compound dosing"><entity charOffset="1-5" id="DDI-PubMed.15526201.s16.e0" text="17AAG" /></sentence><sentence text=" Excluding NSC 683663, the rank order from the highest to the lowest AUC was the same; however, NSC 682300, which ranked fifth, was administered at a four-fold lower individual dose than the other compounds" /><sentence text=" Exposure of the liver and kidneys to the compounds was greater than that of plasma" /><sentence text=" Despite being administered at a lower dose, NSC 682300 displayed the highest kidney AUC of the five compounds" /><sentence text=" The same ranking was maintained between cassette and single compound dosing in the kidney" /><sentence text=" With the exception of NSC 682300, in vitro metabolic stability was predictive of in vivo pharmacokinetics in the plasma and liver" /><sentence text=" The extent of metabolism of four of the five compounds was lower following microsomal incubation in combination compared to incubation alone, suggestive of likely drug-drug interaction in the cassette" /><sentence text=" However, for 17AAG this may be partly due to metabolism of NSC 683661 and NSC 683663 to this compound"><entity charOffset="14-18" id="DDI-PubMed.15526201.s23.e0" text="17AAG" /></sentence><sentence text="" /><sentence text="Whilst cassette dosing has advantages for use in drug discovery, it is probably unsuitable to evaluate the pharmacokinetics of geldanamycin analogues due to non-linear pharmacokinetics and drug-drug interaction"><entity charOffset="127-139" id="DDI-PubMed.15526201.s25.e0" text="geldanamycin" /></sentence><sentence text=" The issues identified for this compound series should also be considered in assessing the suitability of cassette dosing for other chemotypes" /><sentence text="" /></document>